Information required to be published under Information Publication Scheme (IPS)

The Gene Technology Regulator (the Regulator), as a Principal Officer (prescribed authority or an Agency), is subject to the Freedom of Information Act 1982 (the FOI Act). From 1 May 2011 Agencies are required to comply with the Information Publication Scheme (IPS) established by the FOI Act. The IPS promotes transparency and a proactive approach to publishing government information.

The IPS consists of the following three elements (IPS entry):
  • publish an agency plan (subsections 8(1) and 8(2)(a))
  • publish specified categories of information (subsection 8(2))
  • proactively publish other information (subsection 8(4)).
Based on the Agency plan (see below) the following ten categories of information as specified under section 8(2) of the Freedom of Information Act 1982 (the FOI Act) are published below:
  • Agency plan (subsection 8(2)(a) of the FOI Act)
  • Structure of the Agency (subsection 8(2)(b))
  • Functions of the Agency, including decision making powers that affect members of the public (subsection 8(2)(c))
  • Statutory appointments (subsection 8(2)(d))
  • Annual reports and other responses to the Parliament (subsection 8(2)(e))
  • Consultation arrangements (subsection 8(2)(f))
  • Routinely requested information including disclosure log for information released in connection with FOI requests (subsection 8(2)(g)) and section 11C)
  • Routinely provided information in response to requests and orders from the Parliament (subsection 8(2)(h))
  • Contact details of OGTR (subsection 8(2)(i))
  • Operational information (subsection 8(2)(j))
Top of page